RxDoctor Payments Data

Leif-Erik Bohman, MD

Neurological Surgery · Newark, DENPI 1235392945

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,432 of the $4,573 with a category attached, or 75.0%. 12 manufacturers reported payments, led by Medical Device Business Services, Inc. at 26.6% of the total. Reporting peaked in 2019 at $2,103 and has fallen 76.8% since, to $489 in 2025.

$4,573in general payments, 2019–2025

Across 64 payments — averaging $71.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$1K
  • Medtronic$1K
  • Globus Medical$472
  • Abbott$414
  • Johnson & Johnson$340
  • Zap Surgical Systems, Inc.$301
  • plus $784 from 6 others
$20,497in research payments, 2019–2025

Across 13 payments — averaging $1576.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Penumbra, Inc.$20K

What the payments were for

  • Travel & lodging$1,07624%
  • Food & beverage$3,43275%
  • Education$651%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medical Device Business Services, Inc.5$1,216
Medtronic(2 entities)20$1,045
Globus Medical(2 entities)7$472
Abbott7$414
Johnson & Johnson7$340
Zap Surgical Systems, Inc.2$301
Cerapedics Inc.8$245
Si-bone, Inc.3$191
Penumbra, Inc.1$137
Stryker1$123
Novocure Inc.2$71
Alphatec Spine, Inc1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neurological surgery providers in Delawareto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$476,080
Medicare patients
584
Services billed
1,557

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin47$530
Tizanidine Hcl28$181
Cyclobenzaprine Hcl22$124
Methylprednisolone15$114
Oxycodone Hcl25$108

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →